ARX:ASX
Aroa Biosurgery Ltd
A$ ०.५१
arrow_upward
+०.९९%(+०.००५०) 1D
नोभेम्बर १०, १६:१०:२३ GMT+११ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$ ०.५०
High
A$ ०.५२
Low
A$ ०.५०
Mkt. cap
१७.६४ करोड
Avg. vol.
२.९९ लाख
Volume
७८.६५ हजार
P/E ratio
४९.०९
52-wk high
A$ ०.७८
52-wk low
A$ ०.४६
EPS
A$ ०.०१
Shares outstanding
३४.५९ करोड
No. of employees
२६१
Open
A$ ०.५०
High
A$ ०.५२
Low
A$ ०.५०
Mkt. cap
१७.६४ करोड
Avg. vol.
२.९९ लाख
Volume
७८.६५ हजार
P/E ratio
४९.०९
52-wk high
A$ ०.७८
52-wk low
A$ ०.४६
EPS
A$ ०.०१
Shares outstanding
३४.५९ करोड
No. of employees
२६१
News stories
From web sources and news partners
CNBC
·
१ घण्टा पहिले
Anthropic sets price range of $70 to $78 in upcoming IPO as AI lab marches towards Nasdaq
FinancialContent
·
१ घण्टा पहिले
TransDigm’s (NYSE:TDG) Q3 CY2026 sales top estimates, guides for strong full-year sales
24/7 Wall St.
·
९ मिनेट पहिले
3 Highest-Yielding Nasdaq Stocks That Are a Top Buy for December
Investing.com
·
१४ मिनेट पहिले
UBS keeps S&P 500 end-2027 target at 8,900, says derating sets up strong returns
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd